Home•Our Research•Publications•AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome

AntimiR targeting of microRNA-134 reduces seizures in a mouse model of Angelman syndrome

Thematic Area:
Therapeutics
Disease Area:
Rare Neurological Disorders
Research Focus:
Drug DiscoveryNon-coding RNAs
Collaborators:
AcademicIndustry